Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
59 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- Memorial University Medical Center
Savannah, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Oncology Center
Indianapolis, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Greater Baltimore Medical Center
Baltimore, Maryland, United States
- Medstar Franklin Square Medical Center/weinberg Cancer Institute
Baltimore, Maryland, United States
- Michigan Cancer Research Consortium Ncorp
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Genesys Regional Medical Center
Grand Blanc, Michigan, United States
- Allegiance Health
Jackson, Michigan, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Saint Mary Mercy Hospital
Livonia, Michigan, United States
- Saint Joseph Mercy Port Huron
Port Huron, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Mercy Hospital Springfield
Springfield, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Carolinas Healthcare System Northeast
Concord, North Carolina, United States
- Akron General Medical Center
Akron, Ohio, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
- Lake University Ireland Cancer Center
Mentor, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2011
- Primary completion
- 31 Jan 2016
- Completion
- 31 Jan 2016
- Last update posted
- 9 Oct 2017
- Registered enrollment
- 37
- Registry id
- NCT01225887
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.